BioVoice News May 2017 Issue 12 Volume 1 | Page 27

consisting of silver nanoparticles, well known for its antimicrobial effects. The formulation has been shown to be effective against bacteria, spores, and virus, making it twice as effective as current sterilization sprays, while being 10 times safer than current surface sterilization agents. The formulation is designed have a longer residence time on surfaces, saving one from repetitive application. The founders expect the products in pipeline to finish the regulatory pathway and reach the market in next 5 years. The company valued at $1 million, is in full force of its production and sales targeting revenue of $1-2 million per annum. Aggressively moving to make its presence, it aims to capture at least 10-20 percent market share. With high ambitions, the WeInnovate Biosolutions is also looking at starting overseas operations in at least 5 countries, thereby expecting to grow by 10 folds. BIRAC’S FUNDING WAS WORTH IT! BIRAC according to me is the best organization to catalyse the start-up activity in India. We were a group of scientists and hoping to do something to make a change but the decision to form a company rolled in because BIRAC showed the initial trust on us. Apart from just the funding, BIRAC plays a very important role in their funded startup by organising various events and meetings where we get to meet investors, advisors and networking. In all we are very happy by the way BIRAC works and the whole idea behind it. MILIND CHAUDHARI, CEO, WEINNOVATE BIOSOULTIONS BIOVOICENEWS.COM 27